QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

CUSIP: 74754R103

Q2 2020 13F Holders as of 30 Jun 2020

Holder snapshot 5 signals
Share change
+110,857
SEC-reported price per share
$3.97
Number of holders
8
Value change
+$440,635
Number of buys
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
6,138,804

Security key

74754R103

Report period

Q2 2020

Institutions

8

Top holders

8

Ownership snapshot

Top reported holders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
8
Shares
110,857
Rows available
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q3 2022 Across Filers

Q3 2022 holders
22
Q2 2020 holders
8
Holder diff
-14
Investor Q3 2022 Shares Q2 2020 Shares Share Diff Share Chg % Q3 2022 value Q2 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .